ESC Premium Access

Comparison of platelet inhibition in patients with ST-elevation myocardial infarction vs. non-ST elevation myocardial infarction after a loading dose of swallowed vs. chewed ticagrelor.

Congress Presentation

About the speaker

Associate Professor Shlomi Matetzky

Sheba Medical Center, Ramat Gan (Israel)
1 presentation
0 follower

4 more presentations in this session

De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight from the ANTARCTIC trial.

Speaker: Professor G. Cayla (Nimes, FR)

Thumbnail

Diurnal variability of on-treatment platelet reactivity in clopidogrel vs. prasugrel treated acute coronary syndrome patients: a pre-specified TROPICAL-ACS sub-study

Speaker: Doctor R. Hein (Munich, DE)

Thumbnail

Platelet function testing predicts bleeding complications in elderly patients admitted for an acute coronary syndrome: insights from the ANTARCTIC trial

Speaker: Doctor B. Lattuca (Nimes, FR)

Thumbnail

Influence of intravenous fentanyl versus morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI

Speaker: Doctor J. Iglesias (Geneva, CH)

Thumbnail

Access the full session

The role of platelet function in acute coronary syndromes

Speakers: Associate Professor S. Matetzky, Professor G. Cayla, Doctor R. Hein, Doctor B. Lattuca, Doctor J. Iglesias
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb